文章目录

癌症患者的不良后果

原文发布日期：2020-07-31

英文摘要：

摘要翻译：

原文链接：

文章：

癌症患者的不良后果

adverse outcomes in patients with cancer

原文发布日期：2020-07-31

英文摘要：

In 84,246 consecutive Italians tested for SARS-CoV-2, we examined the prevalence of cancer and clinical outcomes of viral infection. Overall, 5.7% (4,789/84,246) had previously been diagnosed with cancer and, among the SARS-CoV-2-positive (CV2+ve) patients, 7.8% had a cancer diagnosis (723/9,275). Prevalence of cancer was not associated with risk of infection (odds ratio of 0.97; 95% confidence interval of 0.89–1.06). The proportion of CV2+ve people hospitalized was higher among patients with cancer (56.6 versus 34.4% among other people), and so was the proportion of deaths (14.7% versus 4.5%). The risk of adverse outcomes of SARS-CoV-2 infection was significantly higher for patients with cancer versus those without, particularly for males and older people.

摘要翻译：

在连续检测了84,246名意大利人感染新冠病毒（SARS-CoV-2）后，我们考察了癌症患病率及病毒感染的临床结果。总体而言，在这84,246名受试者中，有5.7%（即4,789人）曾被诊断出过癌症；而在新冠病毒阳性患者（CV2+ve）中，这一比例为7.8%（723人）。癌症的发病率与感染新冠病毒的风险之间并未显著关联（比值比为0.97；95%置信区间为0.89–1.06）。然而，在接受治疗的患者中，住院率在有癌症的患者中更高（56.6% vs 34.4%），死亡率也是如此（14.7% vs 4.5%）。对于新冠病毒感染而言，与未感染新冠病毒者相比，尤其是对男性和老年人而言，出现不良临床结果的风险显著升高。